![](/img/cover-not-exists.png)
Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level
Windyga, J., Lissitchkov, T., Stasyshyn, O., Mamonov, V., Rusen, L., Lamas, J. L., Oh, M.-S., Chapman, M., Fritsch, S., Pavlova, B. G., Wong, W.-Y., Abbuehl, B. E.Volume:
20
Language:
english
Journal:
Haemophilia
DOI:
10.1111/hae.12228
Date:
January, 2014
File:
PDF, 249 KB
english, 2014